The Effect of Metabolic Diseases on the Outcome of Bevacizumab Injection for Central Serous Retinopathy
Background and Objective: Central serous retinopathy (CSR) is an idiopathic retinal disease that causes visual impairment and metamorphopsia. Due to the unknown etiology of CSR, the present study was conducted to investigate the role of metabolic disorders such as hyperlipidemia, diabetes, hypothyro...
Main Authors: | M Babaei, H Shirafkan, SA Rasoulinejad |
---|---|
Format: | Article |
Language: | English |
Published: |
Babol University of Medical Sciences
2022-03-01
|
Series: | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul |
Subjects: | |
Online Access: | http://jbums.org/article-1-10814-en.html |
Similar Items
-
The Effect of Laser Diode MicroPulse Laser in Patients with Acute Central Serous Retinopathy in Comparison with Control Group: A Clinical Trial Study
by: Heshmatollah Ghanbari, et al.
Published: (2019-08-01) -
Effects of propranolol in patients with central serous chorioretinopathy
by: Farzan Kianersi, et al.
Published: (2008-06-01) -
Effect of Intravitreal Injection of Bevacizumab on Acute Central Serous Chorioretinopathy Patients who Visited Feiz Hospital during 2014–2015 Period
by: Mohamad Reza Akhlaghi, et al.
Published: (2017-01-01) -
Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
by: Maria G. Kotoula, et al.
Published: (2012-06-01) -
Predicting Post-Therapeutic Visual Acuity and OCT Images in Patients With Central Serous Chorioretinopathy by Artificial Intelligence
by: Fabao Xu, et al.
Published: (2021-11-01)